Loading
Insider filings for イノバセル are scarce in the EDINET (Japan FSA) feed, the latest one published on 3 March 2026. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
· cache
Inovacell is a company listed on the Tokyo Stock Exchange, specializing in the biotechnology sector. It focuses on developing innovative solutions for disease treatment.